TBPH Return on Tangible Equity | Theravance Biopharma, Inc.

Theravance Biopharma, Inc. (TBPH) Return on Tangible Equity

2026-06-30: Return Tang Equity 18.57%.
2026-03-31: Return Tang Equity 39.42%.
2025-12-31: Return Tang Equity 35.69%.
2025-09-30: Return Tang Equity 12.61%.

Complete source-backed return tang equity history.

Available history: 2012-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	18.57%
2026-03-31	39.42%
2025-12-31	35.69%
2025-09-30	12.61%
2025-06-30	5.80%
2025-03-31	-35.14%
2024-12-31	-32.14%
2024-09-30	-26.61%
2024-06-30	-23.57%
2024-03-31	-21.85%
2023-12-31	-25.91%
2023-09-30	-23.18%
2023-06-30	310.01%
2023-03-31	236.40%
2022-12-31	197.40%
2022-09-30	176.97%
2022-06-30	29.01%
2022-03-31	41.45%
2021-12-31	58.90%
2021-09-30	69.79%
2021-06-30	87.94%
2021-03-31	73.59%
2020-12-31	91.53%
2020-09-30	109.04%
2020-06-30	133.43%
2020-03-31	156.35%
2019-12-31	105.64%
2019-09-30	120.91%
2019-06-30	161.81%
2019-03-31	196.92%
2018-12-31	417.77%
2018-09-30	1876.24%
2018-06-30	-755.24%
2018-03-31	-449.75%
2017-12-31	-247.79%
2017-09-30	-144.37%
2017-06-30	-96.59%
2017-03-31	-72.75%
2016-12-31	-54.44%
2016-09-30	-56.45%
2016-06-30	-56.44%
2016-03-31	-76.25%
2015-12-31	-74.97%
2015-09-30	-90.63%
2015-06-30	-81.06%
2015-03-31	-75.92%
2014-12-31	-81.80%
2014-09-30	-63.80%
2014-06-30	-52.86%
2014-03-31	1027.73%
2013-12-31	917.43%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	35.69%
2024-12-31	-32.14%
2023-12-31	-25.91%
2022-12-31	197.40%
2021-12-31	58.90%
2020-12-31	91.53%
2019-12-31	105.64%
2018-12-31	417.77%
2017-12-31	-247.79%
2016-12-31	-54.44%
2015-12-31	-74.97%
2014-12-31	-81.80%
2013-12-31	917.43%
2012-12-31	136.98%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Cryoport, Inc. (CYRX)	United States	$0.881B	-21.29
RIGEL PHARMACEUTICALS INC (RIGL)	United States	$0.893B	2.25
Apnimed, Inc. (APMD)	United States	$0.899B
ARDELYX, INC. (ARDX)	United States	$0.857B	-22.86
Avalo Therapeutics, Inc. (AVTX)	United States	$0.842B	-9.74
Immix Biopharma, Inc. (IMMX)	United States	$0.837B	-18.44
Jade Biosciences, Inc. (JBIO)	United States	$0.936B	-9.21
Obsidian Therapeutics, Inc. (OBX)	United States	$0.829B
LEXICON PHARMACEUTICALS, INC. (LXRX)	United States	$0.823B	-17.48
GYRE THERAPEUTICS, INC. (GYRE)	United States	$0.818B	-24.71